Research Article
Cytokines and Effector/Regulatory Cells Characterization in the Physiopathology of Cutaneous Lupus Erythematous: A Cross-Sectional Study
Table 1
Demographic and clinical characteristics from patients with cutaneous lupus erythematosus.
| | HD | HSc | DLE | SCLE | value | | | | | |
| Demographics | | | | | | Age (years) | | | | | | Median | 45 | 29 | 39 | 35 | | Range | (21–76) | (24–33) | (18–74) | (20–62) | 0.003 | Sex (female %) | 100 | 100 | 95 | 93 | NS | Disease duration (years) | | | | | | Median | — | — | 7 | 6 | NS | Range | | | (1–26) | (1–41) | |
| Laboratory variables | | | | | | Leukocytes (cells/mL) | | | | | | Median | 5500 | ND | 5200 | 6100 | NS | Range | (4200–8200) | | (2400–6700) | (2200–15700) | | Lymphocytes (%) | | | | | | Median | 29 | ND | 20 | 19 | 0.028 | Range | (18–47) | (14–33) | (8–33) | ESR (mmHg) | | | | | | Median | 6 | 1 | 8 | 10 | 0.0024 | Range | (2–18) | (1–15) | (2–28) | (2–48) | | Anti-dsDNA (IU/mL) | | | | | | Median | | | 16 | 45 | | Range | — | — | (8–111) | (12–447) | <0.001 | C3 (mg/dL) | | | | | | Median | | | 79 | 79 | | Range | — | — | (24–134) | (29–130) | NS | C4 (mg/dL) | | | | | | Median | — | — | 14 | 14 | NS | Range | | | (8–29) | (6–37) | |
| Clinical variables | | | | | | CLASI activity score | | | | | | Median | | | 11 | 21 | | Range | — | — | (2–25) | (9–37) | <0.001 | Prednisone (mg/day) | | | | | | Median | | | 5 | 10 | | Range | — | — | (0–30) | (0–50) | 0.0037 | Antimalarial (%) | — | — | 75 | 67 | 0.043 |
|
|
HD: healthy donors; HSc: hypertrophic scar; DLE: discoid lupus erythematosus; SCLE: subacute cutaneous lupus erythematosus.
|